These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 32798059)
1. Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency. Du P; Wang A; Ma Y; Jia A; Li Y; Li X Clin Ther; 2020 Sep; 42(9):1799-1810.e3. PubMed ID: 32798059 [TBL] [Abstract][Full Text] [Related]
2. Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency. Du P; Wang A; Ma Y; Jia A; Li Y; Li X Clin Ther; 2021 Apr; 43(4):788. PubMed ID: 33744001 [No Abstract] [Full Text] [Related]
3. A population pharmacokinetic analysis of the influence of nutritional status of digoxin in hospitalized Korean patients. Choi SA; Yun HY; Lee ES; Shin WG Clin Ther; 2014 Mar; 36(3):389-400. PubMed ID: 24612944 [TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model. Yukawa E; Suematu F; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y; Aoyama T Clin Pharmacokinet; 2001; 40(10):773-81. PubMed ID: 11707062 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic analysis of digoxin in Chinese neonates and infants. Gong Y; Chen Y; Li Q; Li Z J Pharmacol Sci; 2014; 125(2):142-9. PubMed ID: 24837877 [TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice. Zhou XD; Gao Y; Guan Z; Li ZD; Li J Acta Pharmacol Sin; 2010 Jun; 31(6):753-8. PubMed ID: 20523346 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of digoxin in elderly patients. Chen R; Zou SL; Wang ML; Jiang Y; Xue H; Qian CY; Xia ZL Eur J Drug Metab Pharmacokinet; 2013 Jun; 38(2):115-21. PubMed ID: 23096939 [TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics of Digoxin in Nonagenarian Patients: Optimization of the Dosing Regimen. Salcedo-Mingoarranz AL; Medellín-Garibay SE; Barcia-Hernández E; García-Díaz B Clin Pharmacokinet; 2023 Dec; 62(12):1725-1738. PubMed ID: 37816957 [TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of digoxin in Korean patients. Nagaraja NV; Park YJ; Jeon S; Sands CD; Derendorf H Int J Clin Pharmacol Ther; 2000 Jun; 38(6):291-7. PubMed ID: 10890577 [TBL] [Abstract][Full Text] [Related]
10. A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population. Abdel Jalil MH; Abdullah N; Alsous MM; Saleh M; Abu-Hammour K Br J Clin Pharmacol; 2020 Jul; 86(7):1267-1280. PubMed ID: 32153059 [TBL] [Abstract][Full Text] [Related]
11. Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis. Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y Biopharm Drug Dispos; 2002 Jul; 23(5):173-81. PubMed ID: 12116048 [TBL] [Abstract][Full Text] [Related]
12. Corrigendum to "Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency" [Clin Therapeut 42(9) 1799-1810]. Du P; Wang A; Ma Y; Jia A; Li Y; Li X Clin Ther; 2021 Apr; 43(4):790. PubMed ID: 34183116 [No Abstract] [Full Text] [Related]
13. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense? el-Desoky ES; Madabushi R; Amry Sel-D; Bhattaram VA; Derendorf H Am J Ther; 2005; 12(4):320-7. PubMed ID: 16041195 [TBL] [Abstract][Full Text] [Related]
14. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis. Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y Eur J Clin Pharmacol; 2001 Apr; 57(1):19-24. PubMed ID: 11372585 [TBL] [Abstract][Full Text] [Related]
15. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling. Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M Drugs Aging; 2011 Oct; 28(10):831-41. PubMed ID: 21970310 [TBL] [Abstract][Full Text] [Related]
16. Population analysis for the optimization of digoxin treatment in Japanese paediatric patients. Suematsu F; Minemoto M; Yukawa E; Higuchi S J Clin Pharm Ther; 1999 Jun; 24(3):203-8. PubMed ID: 10438180 [TBL] [Abstract][Full Text] [Related]
17. Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens. Yukawa E; Mine H; Higuchi S; Aoyama T J Pharm Pharmacol; 1992 Sep; 44(9):761-5. PubMed ID: 1360530 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of the digoxin-quinidine interaction via mixed-effect modelling. Williams PJ; Lane J; Murray W; Mergener MA; Kamigaki M Clin Pharmacokinet; 1992 Jan; 22(1):66-74. PubMed ID: 1559308 [TBL] [Abstract][Full Text] [Related]
19. Efficiency of individual dosage of digoxin with calculated concentration. Zhao L; Yang P; Li P; Wang X; Qin W; Zhang X Clin Interv Aging; 2014; 9():1205-10. PubMed ID: 25092970 [TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization. EL Desoky ES; Nagaraja NV; Derendorf H Am J Ther; 2002; 9(6):492-8. PubMed ID: 12424506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]